Advanced Statistics in Regulatory Critical Clinical Initiatives

The subject of the proposed book primarily focuses on recent critical clinical initiatives as the result of the 21st Century Cure Act passed by the United States Congress in December 2016. The proposed book will include innovative design and analysis ofeach critical clinical initiatives in biopharmaceutical research and development from both regulatory and scientific (statistical) perspectives. The proposed book is designed for pharmaceutical researchers and/or scientists at master or doctoral level ofbiostatistics or related areas--